On the 21st, it was announced that the calcium filler (CaHA) ‘FACETEM’ by bio-regenerative medicine company CGBio (CEO Hyun Seung Yu) has been launched in Indonesia, marking its official entrance into the local calcium filler market.
After launching its hyaluronic acid (HA) fillers Giselleligne and Aileene in 2021, CGBio has achieved a significant milestone this year with the launch of FACETEM, expanding its entire filler range in Indonesia.
The main ingredient of FACETEM, Calcium Hydroxyapatite (CaHA), is a mineral primarily found in structures such as bones and teeth, making it highly biocompatible. Its duration lasts around 1-2 years, double the longevity of hyaluronic acid (HA) fillers. The finger grip section, which supports the index and middle fingers, has a 360-degree rotation feature and a smooth injection feel, improving convenience for the practitioner during the injection of the product.
Especially, FACETEM stimulates collagen production, helping to restore damaged skin structures, enhance elasticity, and improve skin tone. It can be used as a ‘collagen stimulator,’ presenting a unique advantage in capturing the related market share.
As of 2022, the Indonesian filler market is valued at $234 million (approx. 311.9 billion KRW), with an annual growth rate of 11.52%, establishing it as a promising market globally and within Asia. Only three global companies, including CGBio, produce calcium fillers. With this edge, there is ambition to expand the market share in Asia and globally.
CGBio has chosen Indonesia as its second business hub and is expanding its aesthetic surgery-related ventures. Notably, in March 2023, the company opened the ‘NULOOK’ medical aesthetic clinic in Bali, Indonesia, introducing CGBio’s aesthetic surgery products and the latest equipment and tools from Korea, allowing locals to experience high-quality K-beauty.
Furthermore, CGBio recently participated in major dermatological conferences, such as the ‘2023 PIT XIX PERDOSKI in Jakarta,’ which aims to reach out to dermatologists, and ‘EaSWAM,’ which aims to reach out to dermatologists and general practitioners in the eastern region of Java Island. They worked with their local partner, MDBeauty, to set up promotional booths and showcase FACETEM to industry experts. More than 350 medical professionals visited these booths at both conferences, showing high interest in FACETEM.
Additionally, CGBio is actively conducting ‘medical training’ to ensure local medical professionals use FACETEM correctly, providing patients with safe and effective treatments. This support includes introducing the FACETEM product and providing comprehensive procedures based on the characteristics of calcium fillers and procedural know-how to assist medical professionals in effectively administering treatments.
The CEO of CGBio, Hyun Seung Yu, expressed that “Indonesia is one of the rapidly growing countries in Asia, and its aesthetic surgery market also holds immense potential. We’re delighted that with the launch of FACETEM, CGBio’s entire filler line has entered the market. Moving forward, we plan to swiftly capture the market through aggressive marketing activities.”
